The company
Iovance Biotherapeutics, Inc.
IOVA · Nasdaq
IOVA stood above a rising 150-day average in 42 of the last 52 weekly readings, including each of the last 42 weeks. It is 125.5% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 42 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 273 (+7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 36,957,681$153.7M | +5,877,176+18.9% |
| MHR FUND MANAGEMENT LLCunchanged · filed 14 Aug 2026 | 28,967,103$120.5M | 00.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 24,478,268$101.8M | +7,030,160+40.3% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 19,010,697$79.1M | +5,323,264+38.9% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 18,204,248$75.7M | +1,586,511+9.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 14,388,999$59.9M | +2,688,155+23.0% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 10,324,826$43.0M | +1,752,228+20.4% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 8,525,919$35.5M | -888,373−9.4% |
| DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026 | 6,460,449$26.9M | +3,814,747+144.2% |
| Palo Alto Investors LPreduced · filed 17 Aug 2026 | 5,296,209$22.0M | -1,053,354−16.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.